Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-06-13
1998-09-29
Sayala, Chhaya D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 12, 514 21, 514 3, A61K 3828
Patent
active
058146008
ABSTRACT:
Method and compositions for treating a mammal by administering to that mammal an insulin (having the in vitro activity of stimulating glucose incorporation into glycogen in rat soleus muscle) and an amylin (having the in vitro activity of suppressing glucose incorporation into glycogen in rat soleus muscle) using specific molar ratios of an insulin to an amylin.
REFERENCES:
patent: 5124314 (1992-06-01), Cooper
patent: 5234906 (1993-08-01), Young et al.
patent: 5508260 (1996-04-01), Beaumont et al.
patent: 5527771 (1996-06-01), Beaumont et al.
patent: 5686411 (1997-11-01), Gaeta et al.
Rink Timothy J.
Young Andrew A.
Amylin Pharmaceuticals Inc.
Sayala Chhaya D.
LandOfFree
Method and composition for treatment of insulin requiring mammal does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and composition for treatment of insulin requiring mammal, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and composition for treatment of insulin requiring mammal will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-686259